01900nam a2200277 a 4500 vtls000043037 KUKTEM 20251117145148.0 090902t2009 enka b 001 0 eng 9780470092545 (hbk) 0470092548 (hbk) 9780470092552 (pbk) 0470092556 (pbk) 201107132032 VLOAD 201008190925 jamie 200909021419 farina RC271.C5 A57 2009 Airley, Rachel. Cancer chemotherapy / Rachel Airley Chichester, UK ; Hoboken, NJ : Wiley-Blackwell, 2009 x, 341 p., [8] p. of plates : ill. (some col.) ; 25 cm. Includes bibliographical references and index Cancer epidemiology -- Histopathology of cancer -- Carcinogenesis, malignant transformation, and progression -- Molecular biology of cancer : oncogenes and tumour suppressor genes -- Tumour metastasis : a convergence of many theories -- Health professionals in the treatment of cancer -- Principles of cancer chemotherapy -- Classic anticancer agents -- The philosophy of cancer research -- Novel anticancer agents -- Clinical trials -- Tumour hypoxia -- Antiangiogenic and antivascular agents -- Tyrosine kinase inhibitors -- Ras inhibitors -- Inhibitors of the Akt/PKB pathway -- Targeting stress proteins: HSP90 inhibitors -- The proteasome -- Checkpoint protein kinases as novel targets : mammalian target of rapamycin (mTOR) -- Telomerase -- Histone deacetylase : an epigenetic drug target -- Pharmaceutical problems in cancer chemotherapy -- Oncology pharmacy at home and abroad -- Practice exam questions Cancer Chemotherapy Neoplasms drug therapy Antineoplastic Agents therapeutic use 0 0 0 0 10000 10000 2019-09-04 474.60 0 RC271.C5 A57 2009 0000049172 2019-09-04 00:00:00 1 474.60 2019-09-04 OPEN VIRTUA40 40629 40635 VTLSSORT0080*0200*0201*0202*0203*0900*1000*2450*2600*3000*5040*5050*6500*6501*6502*9991